2017

  1. Kristiansen A, Drevin L, Delahunt B, Samaratunga H, Robinson D, Franck Lissbrant I, Stattin P, Egevad L. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study, Pathology. Oct 13 2017. Sammanfattning
  2. Bosco C, Wong C, Garmo H, Crawley D, Holmberg L, Hammar N, Adolfsson J, Stattin P, Van Hemelrijck M. Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists, BJU Int. Sep 20 2017. Sammanfattning
  3. Rajan P, Sooriakumaran P, Nyberg T, Akre O, Carlsson S, Egevad L, Steineck G, Wiklund NP. Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study, J Clin Oncol. Sep 20 2017. Sammanfattning
  4. Ventimiglia E, Folkvaljon Y, Carlsson S, Bratt O, Montorsi F, Volz D, Akre O, Johansson E, Stattin P. Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery, J Surg Oncol. Sep 6 2017. Sammanfattning
  5. Thomsen FB, Sandin F, Garmo H, Lissbrant IF, Ahlgren G, Van Hemelrijck M, Adolfsson J, Robinson D, Stattin P. Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study, Eur Urol. Jul 12 2017. Sammanfattning, Fulltext
  6. Jonas Hugosson, Pär Stattin. Kvaliteten på radikal prostatektomi måste säkerställas-
    Fortlöpande förbättringsarbete behövs på varje klinik – med patientenkäter kan enskilda kirurgers resultat följas upp. Läkartidningen 2017: 114:EP36
  7. Fridriksson JÖ, Folkvaljon Y, Lundström KJ, Robinson D, Carlsson S, Stattin P. Long-term adverse effects after retropubic and robot-assisted radical prostatectomy. Nationwide, population-based study, J Surg Oncol. Jun 7 2017. Sammanfattning
  8. Licciardello MP, Ringler A, Markt P, Klepsch F, Lardeau CH, Sdelci S, Schirghuber E, Müller AC, Caldera M, Wagner A, Herzog R, Penz T, Schuster M, Boidol B, Dürnberger G, Folkvaljon Y, Stattin P, Ivanov V, Colinge J, Bock C, Kratochwill K, Menche J, Bennett KL, Kubicek S. A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor, Nat Chem Biol. May 22 2017. Sammanfattning
  9. Sooriakumaran P, Nyberg T, Akre O, Widmark A, Hamdy F, Graefen M, Carlsson S, Steineck G, Wiklund NP. Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy, Eur Urol. Apr 14 2017. Sammanfattning
  10. Bosco C, Garmo H, Adolfsson J, Stattin P, Holmberg L, Nilsson P, Gunnlaugsson A, Widmark A, Van Hemelrijck M. Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events, Int J Radiat Oncol Biol Phys. Apr 1 2017. Sammanfattning
  11. Crawley D, Garmo H, Rudman S, Stattin P, Zethelius B, Holmberg L, Adolfsson J, Van Hemelrijck M. Association between Type 2 diabetes, curative treatment and survival in men with intermediate and high risk localised prostate cancer, BJU Int. Apr 18 2017. Sammanfattning
  12. Robertson S, Adolfsson J, Stattin P, Sjövall A, Winnersjö R, Hanning M, Sandelin K. Waiting times for cancer patients in Sweden: A nationwide population-based study, Scand J Public Health. May 2017. Sammanfattning
  13. Loeb S, Folkvaljon Y, Damber JE, Alukal J, Lambe M, Stattin P. Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer, J Clin Oncol. May 1 2017. Sammanfattning